M&A

BSV’s 2500+ employees to join Mankind Pharma 

This deal expands DKSH to life science business in the Asia Pacific

Veeda expands its reach to major geographies and adds capabilities of late-stage clinical trial execution with strong focus on…

Expands its business in the UK market, aiming to expand its product portfolio

The merged platform to comprise three distinct business units – Pharma CDMO, Spec Chem CDMO, and API+ (inclusive of formulations)

Deal includes clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and…

With this acquisition, Sterling Accuris has expanded its range of services offered to fields such as pharma analytical testing

The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…

Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain…

Ind-Swift reported a consolidated revenue of Rs 1,207 crores and consolidated EBITDA of Rs 256 crores in FY23